Jonathan Wygant
Known title: VP, Chief Accounting OfficerCIK: 0001584145
Associated companies
Transaction History
| VCYT | ▼ Sell | Tax Withholding | 1,361 | $61K | 9/2/2026 | View on chart |
| VCYT | ▼ Sell | Tax Withholding | 1,361 | $65K | 6/2/2026 | View on chart |
| VCYT | ▲ Buy | Option Exercise | 24,000 | $595K | 5/22/2026 | View on chart |
| VCYT | ▼ Sell | Open Market | 24,000 | $1.1M | 5/22/2026 | View on chart |
| VCYT | ▲ Buy | Grant | 10,525 | $0 | 3/6/2026 | View on chart |
| VCYT | ▼ Sell | Tax Withholding | 3,006 | $108K | 3/2/2026 | View on chart |
| VCYT | ▼ Sell | Tax Withholding | 1,325 | $61K | 12/2/2025 | View on chart |
| VCYT | ▼ Sell | Open Market | 5,102 | $216K | 11/10/2025 | View on chart |
| VCYT | ▼ Sell | Open Market | 5,818 | $234K | 11/7/2025 | View on chart |
| VCYT | ▲ Buy | Grant | 2,886 | $0 | 10/28/2025 | View on chart |
| VCYT | ▼ Sell | Tax Withholding | 1,648 | $50K | 9/2/2025 | View on chart |
| VCYT | ▼ Sell | Tax Withholding | 1,848 | $49K | 6/2/2025 | View on chart |
| VCYT | ▲ Buy | Grant | 13,288 | $0 | 3/6/2025 | View on chart |
| VCYT | ▼ Sell | Tax Withholding | 4,301 | $150K | 3/2/2025 | View on chart |
| VCYT | ▼ Sell | Open Market | 956 | $41K | 12/3/2024 | View on chart |
| VCYT | ▼ Sell | Tax Withholding | 1,087 | $48K | 12/2/2024 | View on chart |
| VCYT | ▼ Sell | Open Market | 5,032 | $216K | 11/27/2024 | View on chart |
| VCYT | ▼ Sell | Tax Withholding | 1,087 | $34K | 9/2/2024 | View on chart |
| VCYT | ▼ Sell | Tax Withholding | 1,087 | $23K | 6/2/2024 | View on chart |
| VCYT | ▲ Buy | Grant | 23,942 | $0 | 3/6/2024 | View on chart |
| VCYT | ▼ Sell | Tax Withholding | 2,337 | $56K | 3/2/2024 | View on chart |
| VCYT | ▼ Sell | Tax Withholding | 507 | $13K | 12/2/2023 | View on chart |
| VCYT | ▼ Sell | Tax Withholding | 1,247 | $33K | 9/2/2023 | View on chart |
| VCYT | ▼ Sell | Tax Withholding | 260 | $7K | 6/2/2023 | View on chart |
| VCYT | ▲ Buy | Grant | 8,868 | $0 | 3/6/2023 | View on chart |
| VCYT | ▼ Sell | Tax Withholding | 1,224 | $29K | 3/2/2023 | View on chart |
| VCYT | ▲ Buy | Grant | 8,561 | $0 | 8/5/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 11, 2026
Veracyte (VCYT) Stock Seen as Undervalued After 107% Rise
Recent coverage notes that Veracyte’s shares have risen more than 100% while still appearing inexpensive relative to its earnings multiple. The company’s trailing P/E of about 30.6 and an analyst consensus target near $58 suggest the market may be pricing in further upside. The stock is currently trading near the lower end of its 52‑week range, close to a support level that has been tested multiple times.
Veracyte (VCYT) Stock Seen as Undervalued After 107% Rise. Recent coverage notes that Veracyte’s shares have risen more than 100% while still appearing inexpensive relative to its earnings multiple. The company’s trailing P/E of about 30.6 and an analyst consensus target near $58 suggest the market may be pricing in further upside. The stock is currently trading near the lower end of its 52‑week range, close to a support level that has been tested multiple times.